| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2012PLoSO...743572S |
| P356 | DOI | 10.1371/JOURNAL.PONE.0043572 |
| P932 | PMC publication ID | 3423360 |
| P698 | PubMed publication ID | 22916279 |
| P5875 | ResearchGate publication ID | 230723548 |
| P50 | author | Steffen Massberg | Q91105776 |
| Jaroslav Pelisek | Q91714534 | ||
| Johann Bauersachs | Q21190988 | ||
| P2093 | author name string | Christian Schulz | |
| Andreas Schäfer | |||
| Michael Lorenz | |||
| Marie-Luise von Brühl | |||
| Paul F Bray | |||
| Moritz Stolla | |||
| Anca Tirniceriu | |||
| Peter Heider | |||
| Verena Barocke | |||
| Alexander Steinhart | |||
| P2860 | cites work | Transmembrane chemokines: versatile 'special agents' in vascular inflammation. | Q53555496 |
| Human fractalkine mediates leukocyte adhesion but not capture under physiological shear conditions; a mechanism for selective monocyte recruitment. | Q54650911 | ||
| Linked Chromosome 16q13 Chemokines, Macrophage-Derived Chemokine, Fractalkine, and Thymus- and Activation-Regulated Chemokine, Are Expressed in Human Atherosclerotic Lesions | Q59704063 | ||
| A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association | Q72415283 | ||
| ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree | Q72689998 | ||
| A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection | Q73209237 | ||
| The chemokine CX3CL1 regulates NK cell activity in vivo | Q75212039 | ||
| Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease | Q78594580 | ||
| Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1) | Q79214234 | ||
| Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation | Q80388691 | ||
| Upregulation of fractalkine and its receptor, CX3CR1, is associated with coronary plaque rupture in patients with unstable angina pectoris | Q82282569 | ||
| Pathology of the vulnerable plaque | Q83187650 | ||
| Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion | Q24311291 | ||
| Analyzing real-time PCR data by the comparative C(T) method | Q28131831 | ||
| Interleukin-7-mediated inflammation in unstable angina: possible role of chemokines and platelets | Q28195974 | ||
| Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease | Q28206251 | ||
| A new class of membrane-bound chemokine with a CX3C motif | Q28303204 | ||
| Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior | Q29616447 | ||
| Macrophages in the pathogenesis of atherosclerosis | Q29617765 | ||
| Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion | Q29618089 | ||
| Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent | Q30440410 | ||
| CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-gamma production, and macrophage accumulation in the aortic wall | Q30444644 | ||
| Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue | Q30978459 | ||
| Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root | Q33580505 | ||
| Intracellular and surface distribution of monocyte tissue factor: application to intersubject variability | Q34469955 | ||
| Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis | Q34828549 | ||
| Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression | Q34876397 | ||
| Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans | Q34912596 | ||
| Quantitative gene expression profiling in formalin-fixed, paraffin-embedded tissues using universal bead arrays | Q35103313 | ||
| Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques | Q35250952 | ||
| Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis | Q35554610 | ||
| In vivo structure/function and expression analysis of the CX3C chemokine fractalkine | Q35865080 | ||
| Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo | Q36238074 | ||
| A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo | Q36370457 | ||
| Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow | Q36404237 | ||
| EMMPRIN (CD147/basigin) mediates platelet-monocyte interactions in vivo and augments monocyte recruitment to the vascular wall | Q39592493 | ||
| A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. | Q40467498 | ||
| Fractalkine, a CX3C-chemokine, functions predominantly as an adhesion molecule in monocytic cell line THP-1. | Q40797648 | ||
| An evaluation of methods for imaging and quantifying coronary and carotid lumen stenosis and atherosclerosis. | Q40881431 | ||
| Characterization and functional properties of tumor cell lines in accessory cell replacement assays. | Q41462147 | ||
| A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation | Q41824616 | ||
| ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6 | Q42136332 | ||
| Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis | Q43726338 | ||
| Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes | Q44310088 | ||
| Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo | Q45764285 | ||
| Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy | Q46191844 | ||
| Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. | Q46652724 | ||
| Overexpression of CXCL16 promotes a vulnerable plaque phenotype in Apolipoprotein E-Knockout Mice | Q50550915 | ||
| An engineered CX3CR1 antagonist endowed with anti-inflammatory activity. | Q51778397 | ||
| Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets. | Q51795566 | ||
| Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. | Q52549466 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | e43572 | |
| P577 | publication date | 2012-08-20 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Fractalkine is expressed in early and advanced atherosclerotic lesions and supports monocyte recruitment via CX3CR1. | |
| P478 | volume | 7 |
| Q35907998 | Aspirin Action in Endothelial Cells: Different Patterns of Response Between Chemokine CX3CL1/CX3CR1 and TNF-α/TNFR1 Signaling Pathways |
| Q90556187 | CX3CL1-Fc treatment prevents atherosclerosis in Ldlr KO mice |
| Q37338290 | CX3CR1 receptor polymorphisms, Th1 cell recruitment, and acute myocardial infarction outcome: looking for a link. |
| Q38131299 | Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway. |
| Q52691045 | DEC205-DC targeted DNA vaccine against CX3CR1 protects against atherogenesis in mice. |
| Q89976448 | Development of Fractalkine-Targeted Nanofibers that Localize to Sites of Arterial Injury |
| Q40638929 | Effects of Porphyromnonas gingivalis lipopolysaccharide on the expression of RANTES and fractalkine in human urnbilical vein endothelial cells |
| Q47805638 | Fractalkine in obstructive sleep apnea patients |
| Q54336718 | Functional analysis of the fractalkine gene promoter in human aortic smooth muscle cells exposed to proinflammatory conditions. |
| Q38400503 | Modulation of platelet and monocyte function by the chemokine fractalkine (CX3 CL1) in cardiovascular disease |
| Q36085817 | Monocyte Chemotactic Protein-1, Fractalkine, and Receptor for Advanced Glycation End Products in Different Pathological Types of Lupus Nephritis and Their Value in Different Treatment Prognoses |
| Q36846847 | Monocyte Subsets and Related Chemokines in Carotid Artery Stenosis and Ischemic Stroke |
| Q34292590 | Neferine inhibits angiotensin II-induced rat aortic smooth muscle cell proliferation predominantly by downregulating fractalkine gene expression |
| Q36317219 | Plasma fractalkine is a sustained marker of disease severity and outcome in sepsis patients. |
| Q38813214 | Role of CX3CL1 in Diseases |
| Q42201674 | Shear Stress Counteracts Endothelial CX3CL1 Induction and Monocytic Cell Adhesion. |
| Q58758009 | The Pathogenesis of Atherosclerosis Based on Human Signaling Networks and Stem Cell Expression Data |
| Q33615950 | The temporal dynamics of plasma fractalkine levels in ischemic stroke: association with clinical severity and outcome |
| Q37581232 | Understanding how we age: insights into inflammaging |
| Q92559131 | VHH antibody targeting the chemokine receptor CX3CR1 inhibits progression of atherosclerosis |
| Q48293548 | Yolk sac macrophage progenitors traffic to the embryo during defined stages of development. |
Search more.